Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-03-04

Clinical Trial Update: New Cysteamine Eye Drops Formulation to Treat Corneal Crystals in Cystinosis [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating a new cysteamine eye drop formulation to treat corneal crystals in cystinosis completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cysteamine eye drops (cysteamine)

Snippet

Sponsor: National Eye Institute (NEI) | Conditions: Cystinosis | Phase 1 | Status: COMPLETED